VBI Vaccines
Cambridge
About VBI Vaccines
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus. VBI is headquartered in Cambridge, MA with research facilities in Ottawa, Canada.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $68.8M
- Funding stage: M&A
- Last round: Post-IPO Equity (Aug 2015)
- Ticker: nasdaq:VBIV
- Website: vbivaccines.com
- Phone: 16137384178
Industries & Categories
Biotechnology, Clinical Trials, Health Care
Social Profiles
Canonical: https://fsome.com/organization/vbi-vaccines-3198527 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.